ATHA Athira Pharma, Inc. Common Stock BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) Best Biotech Stocks 2026 →

Athira Pharma (ATHA) Stock: Buy, Sell, or Hold?

$6.75
-0.44 (-6.12%) â–ŧ
5d: -3.02% 30d: +73.75% 90d: +72.19%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (54%)
Quality Score
38/100
Position
FAIR
Forward P/E & Valuation
-1.3x
Next 12M consensus est.
Wall Street Target
$4.00
-40.7% vs target
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$6.41 / $7.77
Trend: Strong Uptrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
â„šī¸ NEUTRAL: ATHA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.

Get Alerted When ATHA Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: ATHA is currently trading at $6.75, which is considered fair based on recent price action.

Technical Outlook: Technically, ATHA is in a strong uptrend. Immediate support is located at $6.41, while resistance sits at $7.77. Short-term momentum is weak, with the stock down 6.1% recently.

Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. However, the stock is trading significantly above the average Wall Street target of $4.00. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Company Quality Score 38/100 (SELL)
Volume Confirmation UNKNOWN
Confidence Score 53.7%

Trading Range & Key Levels

Support Level $6.41
Resistance Level $7.77
Current Trend Strong Uptrend
Technical data as of Jan 9, 2026

Quantitative Signal Breakdown

  • NEUTRAL: Price in fair range
  • NEUTRAL: Mixed technical signals (55/100)
  • BEARISH: Downward momentum (-6.1%)
  • BEARISH: Trading 40.7% above Wall St target ($4.00)
  • WARNING: Composite score 38/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -1.34
Wall Street Target $4.00 (-40.7%)
Share ATHA Analysis

Share this live ATHA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (ATHA)

Bearish 2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Apr 14, 2026
Daily AI digest
AI Retail Discussion Summary: Bearish sentiment prevails on $ATHA with one user expressing caution on StockTwits.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 16, 2026 1:59 PM ET
Data refreshes hourly during market hours. Next update: 2:59 PM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for ATHA.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ALNY
Alnylam Pharmaceuticals â€Ļ
STRONG BUY
30 analysts
$300 60 HOLD
ONC
BeOne Medicines AG
STRONG BUY
27 analysts
$469 36 SELL
VRTX
Vertex Pharmaceuticals Iâ€Ļ
STRONG BUY
32 analysts
$595 35 SELL
KURA
Kura Oncology Inc
STRONG BUY
16 analysts
$32 63 BUY
ASND
Ascendis Pharma AS
STRONG BUY
21 analysts
$315 34 SELL
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals